CTIM-05. FINAL RESULTS OF 2-THE-TOP: A PILOT PHASE 2 STUDY OF TTFIELDS (OPTUNE) PLUS PEMBROLIZUMAB PLUS MAINTENANCE TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM)

Authors: David Tran, Ashley Ghiaseddin, Dongjiang Chen, Son Le, Maryam Rahman

Published: 2022-11-14

DOI: 10.1093/neuonc/noac209.237

Source: Full article